|Articles|June 7, 2004
FDA may pull digitalis elixirs this month
The FDA deadline for digoxin manufacturers to submit an NDA for their products is fast approaching
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Overcoming the Structural Squeeze Through Policy and Coordination
2
Navigating Compounding Peptides and GLP-1s Through Regulations
3
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
4
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
5






















